Spinal Cord Stimulators for Chronic Back Pain Win FDA Approval On May 16, 2023, the U.S. Food and Drug Administration (FDA) approved spinal cord stimulation (SCS) devices from the pharmaceutical company Abbott to treat chronic back pain in people who have not had or are not eligible to receive back surgery, per a press release from Abbott . Approval was granted after a six-month study of 200 participants showed that spinal cord stimulation provided significant relief and improvements in pain, function, quality of life, and mental health.Those enrolled in the trial had experienced an average of nearly 13 years of disabling chronic back pain. Participants were not eligible for corrective back operations because they were either medically frail or they had numerous degenerative changes in their spine, none of which were severe enough to qualify for corrective surgery but are nonetheless causing significant symptoms. After half a year, 85 percent of those implanted ...
Spinal Cord Stimulators for Chronic Back Pain Win FDA Approval On May 16, 2023, the U.S. Food and Drug Administration (FDA) approved spinal cord stimulation (SCS) devices from the pharmaceutical company Abbott to treat chronic back pain in people who have not had or are not eligible to receive back surgery, per a press release from Abbott . Approval was granted after a six-month study of 200 participants showed that spinal cord stimulation provided significant relief and improvements in pain, function, quality of life, and mental health.Those enrolled in the trial had experienced an average of nearly 13 years of disabling chronic back pain. Participants were not eligible for corrective back operations because they were either medically frail or they had numerous degenerative changes in their spine, none of which were severe enough to qualify for corrective surgery but are nonetheless causing significant symptoms. After half a year, 85 percent of those implanted ...